Medication info
Antikranjeong 625 mg (Amoxicillin and Clavulanate Potassium)

Antikranjeong 625 mg (Amoxicillin and Clavulanate Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Korea Pavis Pharmaceutical Co., Ltd.
Appearance
The tablets are white or nearly white, oval-shaped, and film-coated.
Packaging
40 tablets (4 tablets/PTP x 10)
Approval status
Active

MFDS item code 201602320 · Approved 2016.04.26 · Insurance code 621802830

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections; genitourinary infections; and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally three times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer amoxicillin/potassium clavulanate 250mg/125mg or 500mg/125mg per dose every 12 hours. 10 mL/min or less: Administer amoxicillin/potassium clavulanate 250mg/125mg or 500mg/125mg per dose every 24 hours. Hemodialysis: Administer amoxicillin/potassium clavulanate 250mg/125mg or 500mg/125mg per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanate decrease.)
Child dose
Children 12 years of age or older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally three times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Korea Pavis Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections; genitourinary infections; and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar and bronchial pneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
  • gonorrhea
View approved original text

This medication is used to treat various infections caused by different bacteria. It improves respiratory infections such as acute and chronic bronchitis, lobar and bronchial pneumonia, empyema, lung abscess, tonsillitis, sinusitis, and otitis media. It is also effective against urinary tract infections such as cystitis, urethritis, pyelonephritis, pelvic infections, and gonorrhea. Additionally, it is used to treat skin conditions such as boils, abscesses, soft tissue infections, wound infections, as well as osteomyelitis and dental infections. This medication is effective against a variety of bacteria including Staphylococcus aureus, Escherichia coli, Salmonella, and Neisseria gonorrhoeae, making it widely applicable for the treatment of various bacterial infections. Therefore, it can be safely used for the treatment of multiple infections.

How to take

Adult dose

The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally three times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer amoxicillin/potassium clavulanate 250mg/125mg or 500mg/125mg per dose every 12 hours. 10 mL/min or less: Administer amoxicillin/potassium clavulanate 250mg/125mg or 500mg/125mg per dose every 24 hours. Hemodialysis: Administer amoxicillin/potassium clavulanate 250mg/125mg or 500mg/125mg per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanate decrease.)

Child dose

Children 12 years of age or older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally three times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. Children: Reduce the dose in the same manner.

Precautions

This medication is a beta-lactam antibiotic and should not be used in patients who are allergic or have had hypersensitivity reactions to penicillin. Patients with infectious mononucleosis or lymphocytic leukemia are at higher risk of rash and should be monitored closely. Patients with impaired liver function or a history of liver disorders should also use this medication with caution, and dosing intervals should be adjusted in cases of moderate to severe kidney impairment. Patients with allergic dispositions, elderly individuals, or those with poor nutritional status may experience side effects such as vitamin K deficiency, so caution is advised. If any unusual symptoms such as diarrhea, abdominal pain, skin rash, or difficulty breathing occur during the course of treatment, usage should be stopped immediately and medical advice sought. Regular liver and kidney function tests should be conducted, and prolonged use should be monitored for the development of resistant bacteria and superinfection with non-susceptible organisms. Pregnant women in early pregnancy or those who are breastfeeding should use this medication cautiously and it is advisable to avoid its use if possible. This medication may interact with other drugs, therefore, it is essential to inform healthcare providers of any other medications being taken. In case of overdose, symptoms such as vomiting, diarrhea, kidney failure, and convulsions may occur, requiring immediate medical attention. Store in a dry place at or below 25 degrees Celsius and adhere strictly to the prescribed dosage and administration as directed by a physician.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • indigestion
  • stomatitis
  • gastritis
  • glossitis
  • black hairy tongue
  • nausea
  • vomiting
  • loss of appetite
Show 74 more
  • abdominal pain
  • abdominal bloating
  • constipation
  • colonic pain
  • hyperacidity
  • soft stools
  • xerostomia
  • acute pancreatitis
  • candidiasis
  • antibiotic-associated colitis
  • bloody stools
  • itching
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • vesicular exfoliative dermatitis
  • acute generalized pustular dermatosis
  • eosinophilia
  • angioedema
  • anaphylaxis
  • serum sickness-like syndrome
  • hypersensitivity vasculitis
  • bronchospasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphocytopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vaginal itching
  • burning sensation
  • increased secretion
  • anxiety
  • unrest
  • behavioral changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • convulsions
  • antispasmodic
  • fever
  • altered consciousness
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • vitamin K deficiency symptoms
  • vitamin B complex deficiency symptoms
  • linear IgA disease
  • taste disturbance
  • lethargy
  • dermatitis
  • oral edema
  • gastralgia
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • renal failure
  • interstitial cerebral convulsion
  • hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is contained in a tightly sealed container to prevent moisture and should be stored in a cool temperature between 1 and 25 degrees Celsius. It is important to avoid direct sunlight or high temperatures and not to place it in humid areas.

Appearance and packaging

Appearance

The tablets are white or nearly white, oval-shaped, and film-coated.

Package unit

40 tablets (4 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.